BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 8618249)

  • 1. The use of ondansetron in the treatment of nausea and vomiting associated with acetaminophen poisoning.
    Clark RF; Chen R; Williams SR; Johnson CL; Harchelroad F
    J Toxicol Clin Toxicol; 1996; 34(2):163-7. PubMed ID: 8618249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of ondansetron and other antiemetics in the management of toxic acetaminophen ingestions.
    Scharman EJ
    J Toxicol Clin Toxicol; 1998; 36(1-2):19-25. PubMed ID: 9541036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ondansetron is safe and effective for prehospital treatment of nausea and vomiting by paramedics.
    Salvucci AA; Squire B; Burdick M; Luoto M; Brazzel D; Vaezazizi R
    Prehosp Emerg Care; 2011; 15(1):34-8. PubMed ID: 21091329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of a compassionate-use program using intravenous ondansetron to prevent nausea and vomiting in patients receiving emetogenic cancer chemotherapy.
    Berry WR; House KW; Lee JT; Plagge PB; Meshad MW; Grapski R
    Semin Oncol; 1992 Dec; 19(6 Suppl 15):33-7. PubMed ID: 1485180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ondansetron for treating nausea and vomiting in the poisoned patient.
    Reed MD; Marx CM
    Ann Pharmacother; 1994 Mar; 28(3):331-3. PubMed ID: 8193420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the efficacy, safety, and patient satisfaction of ondansetron versus droperidol as antiemetics for elective outpatient surgical procedures. S3A-409 and S3A-410 Study Groups.
    Fortney JT; Gan TJ; Graczyk S; Wetchler B; Melson T; Khalil S; McKenzie R; Parrillo S; Glass PS; Moote C; Wermeling D; Parasuraman TV; Duncan B; Creed MR
    Anesth Analg; 1998 Apr; 86(4):731-8. PubMed ID: 9539593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ondansetron versus metoclopramide in the treatment of postoperative nausea and vomiting.
    Polati E; Verlato G; Finco G; Mosaner W; Grosso S; Gottin L; Pinaroli AM; Ischia S
    Anesth Analg; 1997 Aug; 85(2):395-9. PubMed ID: 9249120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Prophylactic Ondansetron with Intravenous Opioids in Emergency Department Patients: A Prospective Observational Pilot Study.
    Culver MA; Richards EC; Jarrell DH; Edwards CJ
    J Emerg Med; 2017 Nov; 53(5):629-634. PubMed ID: 28987314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of postoperative nausea and vomiting with ondansetron: a randomized, double-blind comparison with placebo.
    Larijani GE; Gratz I; Afshar M; Minassian S
    Anesth Analg; 1991 Sep; 73(3):246-9. PubMed ID: 1831015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palonosetron is nonsuperior to ondansetron in acute phase but provides superior antiemetic control in delayed phase for pediatric patients administered highly emetogenic chemotherapy.
    Tan J; Wang S; Liang X; Li CC; Zhang J; Zhao Z; Kong XR; Deng X; Peng L; Yang C
    Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28941006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Droperidol/ondansetron combination controls nausea and vomiting after tubal banding.
    McKenzie R; Uy NT; Riley TJ; Hamilton DL
    Anesth Analg; 1996 Dec; 83(6):1218-22. PubMed ID: 8942589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind, randomized comparison of the antiemetic efficacy of intravenous dolasetron mesylate and intravenous ondansetron in the prevention of acute cisplatin-induced emesis in patients with cancer. Dolasetron Comparative Chemotherapy-induced Emesis Prevention Group.
    Hesketh P; Navari R; Grote T; Gralla R; Hainsworth J; Kris M; Anthony L; Khojasteh A; Tapazoglou E; Benedict C; Hahne W
    J Clin Oncol; 1996 Aug; 14(8):2242-9. PubMed ID: 8708713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparable safety and antiemetic efficacy of a brief (30-second bolus) intravenous granisetron infusion and a standard (15-minute) intravenous ondansetron infusion in breast cancer patients receiving moderately emetogenic chemotherapy.
    Perez EA; Lembersky B; Kaywin P; Kalman L; Yocom K; Friedman C
    Cancer J Sci Am; 1998; 4(1):52-8. PubMed ID: 9467047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the emetogenic potential of intrathecal chemotherapy and response to prophylactic treatment with ondansetron.
    Holdsworth MT; Raisch DW; Winter SS; Chavez CM
    Support Care Cancer; 1998 Mar; 6(2):132-8. PubMed ID: 9540172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haloperidol vs. ondansetron for the prevention of postoperative nausea and vomiting following gynaecological surgery.
    Aouad MT; Siddik-Sayyid SM; Taha SK; Azar MS; Nasr VG; Hakki MA; Zoorob DG; Baraka AS
    Eur J Anaesthesiol; 2007 Feb; 24(2):171-8. PubMed ID: 16938159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scottish and Newcastle antiemetic pre-treatment for paracetamol poisoning study (SNAP).
    Thanacoody HK; Gray A; Dear JW; Coyle J; Sandilands EA; Webb DJ; Lewis S; Eddleston M; Thomas SH; Bateman DN
    BMC Pharmacol Toxicol; 2013 Apr; 14():20. PubMed ID: 23556549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of Olanzapine Combined with Ondansetron in Prevention of Chemotherapy-Induced Nausea and Vomiting of Non-small Cell Lung Cancer.
    Wang X; Wang L; Wang H; Zhang H
    Cell Biochem Biophys; 2015 Jun; 72(2):471-3. PubMed ID: 25567657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical efficacy of GG032X tablets, a new dosage form of ondansetron (fast dispersing tablet), on cisplatin-induced nausea and emesis].
    Ariyoshi Y; Nukariya N; Akasaka Y; Suminaga M; Ota J; Ikeda M; Taguchi T
    Gan To Kagaku Ryoho; 1997 Jun; 24(8):995-1011. PubMed ID: 9212810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of single-dose oral granisetron versus intravenous ondansetron in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy: a multicenter, double-blind, randomized parallel study.
    Perez EA; Hesketh P; Sandbach J; Reeves J; Chawla S; Markman M; Hainsworth J; Bushnell W; Friedman C
    J Clin Oncol; 1998 Feb; 16(2):754-60. PubMed ID: 9469367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No more than necessary: safety and efficacy of low-dose promethazine.
    Moser JD; Caldwell JB; Rhule FJ
    Ann Pharmacother; 2006 Jan; 40(1):45-8. PubMed ID: 16352779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.